Suppr超能文献

传播现有最佳证据:医疗保健公共报告中的新挑战。

Disseminating the best available evidence: New challenges in public reporting of health care.

作者信息

Barkhordarian André, Ramchandani Manisha H, Dousti Mahsa, Kelly-Gleason Lauren, Chiappelli Francesco

出版信息

Bioinformation. 2012;8(7):293-5. doi: 10.6026/97320630008293. Epub 2012 Apr 13.

Abstract

As a direct benefit of the Health Care Reform Act (2010), concerted effort has been deployed to define and characterize the process by which the best available evidence for diagnosis or treatment intervention prognosis can be obtained. The science of research synthesis in health care has established the systematic research protocol by which randomized clinical trials and other clinical studies must be reviewed and compared for the level and quality of the evidence presented, as well as the consensus of the best available evidence synthesized and shared. This process of systematic review yields a reliable and valid approach in comparing different interventions and strategies to prevent, diagnose, treat and monitor health conditions in terms of efficacy, and or of effectiveness. The resulting bioinformation outcome of comparative effectiveness and efficacy research review of the available clinical data is expressed as a consensus of the best available evidence, which finds its way in evidence-based clinical practice guidelines, standards of care and eventually, in policies: hence, the acronym CEERAP (comparative effectiveness and efficacy review and policy). The methodological and the procedural criteria that determine and regulate the public reporting dissemination of this sort of bioinformation, and the extent of benefit to the patient's health literacy, which have remained a bit more elusive to this date, are investigated and discussed in this paper.

摘要

作为《医疗保健改革法案》(2010年)的一项直接成果,人们已齐心协力去界定和描述获取诊断、治疗干预预后方面最佳现有证据的过程。医疗保健领域的研究综合科学已确立了系统的研究方案,通过该方案,必须对随机临床试验和其他临床研究进行审查和比较,以评估所呈现证据的水平和质量,以及综合和共享的最佳现有证据的共识。这种系统评价过程在比较不同干预措施和策略在预防、诊断、治疗和监测健康状况方面的疗效和/或有效性时,产生了一种可靠且有效的方法。对现有临床数据进行比较有效性和疗效研究审查所得到的生物信息结果,以最佳现有证据的共识形式呈现,这一共识体现在循证临床实践指南、护理标准中,并最终体现在政策中:因此,就有了CEERAP(比较有效性和疗效审查与政策)这一缩略词。本文对确定和规范这类生物信息公开报告传播的方法和程序标准,以及对患者健康素养的受益程度进行了调查和讨论,而这些在目前仍有点难以捉摸。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/357b/3338971/9f0596b638f5/97320630008293F1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验